Filing Details
- Accession Number:
- 0000950170-25-044374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-25 16:10:05
- Reporting Period:
- 2025-03-21
- Filing Date:
- 2025-03-25
- Accepted Time:
- 2025-03-25 16:10:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651311 | Merus N.v. | MRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1791115 | Harry Shuman | C/O Merus N.v. Uppsalalaan 17 Utrecht P7 3584 CT | Vp Controller, Pao | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2025-03-21 | 2,000 | $0.00 | 14,002 | No | 4 | M | Direct | |
Common Shares | Acquisiton | 2025-03-21 | 1,000 | $0.00 | 15,002 | No | 4 | M | Direct | |
Common Shares | Disposition | 2025-03-21 | 3,000 | $48.48 | 12,002 | No | 4 | S | Direct | |
Common Shares | Disposition | 2025-03-21 | 1,000 | $48.55 | 11,002 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Share Option (right to buy) | Disposition | 2025-03-21 | 2,000 | $0.00 | 2,000 | $24.61 |
Common Shares | Share Option (right to buy) | Disposition | 2025-03-21 | 1,000 | $0.00 | 1,000 | $18.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,000 | 2032-01-31 | No | 4 | M | Direct | |
9,200 | 2030-02-14 | No | 4 | M | Direct |
Footnotes
- Represents the exercise price of the options originally granted on January 31, 2022.
- Represents the exercise price of the options originally granted on February 14, 2020.
- Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter.
- Options vest over a four-year period from January 1, 2022. 25% vest on January 1, 2023 and in 36 equal monthly installments thereafter.